Richard Choe pointed to SoftBank’s long-standing focus on AI, data centers, and advanced computing as signals that ...

Two athletes from Prince Edward Island are one step closer to the Olympics after being selected for funding and accelerated ...

In October, HASI closed a $1.2 billion preferred equity investment in SunZia, North America’s largest clean energy ...

The amount of taxes, fees and expenses a family may have to pay when a loved one dies are often underestimated. That can ...

On December 18, RBC Capital lowered its price target on Canadian National Railway Company (NYSE:CNI) to C$153 from C$158 and ...

On December 19, RBC Capital raised its price target on Accenture plc (NYSE:ACN) to $295 from $285 and kept an Outperform ...

The case in point are the servers used as part of the Google Global Cache system that expedites the content delivery for users ...

HWM is set to acquire CAM from Stanley Black for $1.8 billion, boosting its aerospace fastening solutions portfolio and market reach.

Biohaven said on Wednesday its experimental depression drug did not meet the main goal of a mid-stage trial, adding to a string of trial and regulatory setbacks for the drugmaker this year.

Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red blood cell (RBC) sickling and hemolytic ...

Ingram Micro (INGM) makes RBC Capital’s list, with strong prospects for margin expansion in fiscal 2026. The company is strategically growing its Advanced Solutions and cloud portfolio, which ...